B-IMMUNE final analysis: a phase Ib/II study of durvalumab combined with dose-dense EC in a neoadjuvant setting for patients with locally advanced luminal B HER2(-) or triple negative breast cancers Alix Devaux, Gabriela Beniuga, Claire Quaghebeur,Stephanie Henry,Mieke Van Bockstal,Christine Galant,Paul Delree,Jean-Luc Canon, Brigitte Honhon, Dominique Korman,Vincent Verschaeve, Christophe Lonchay, Sarah Lefevre,Lionel D'Hondt,Martine Berliere, Sophie Delmarcelle, Jean-Michel Mine, Timour Willems, Gebhard Mueller, Nathalie Myant,Isabelle Bar, Sandy Haussy,Pierre G. Coulie,Francois P. Duhoux,Javier CarrascoCANCER RESEARCH（2023）引用 1|浏览13暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
